First investigations on serum resistance and sensitivity of Borrelia turcica.


Journal

Ticks and tick-borne diseases
ISSN: 1877-9603
Titre abrégé: Ticks Tick Borne Dis
Pays: Netherlands
ID NLM: 101522599

Informations de publication

Date de publication:
08 2019
Historique:
received: 01 04 2019
revised: 04 06 2019
accepted: 15 06 2019
pubmed: 27 6 2019
medline: 20 11 2019
entrez: 27 6 2019
Statut: ppublish

Résumé

Borrelia turcica is a reptile-associated Borrelia species that is vectored by the hard tick Hyalomma aegyptium. Tortoises of the genus Testudo represent the principal host of adult H. aegyptium, while immature stages are less host-specific and can be found on various vertebrates and even on humans. Borrelia turcica isolates were already successfully obtained from exotic tortoises suggesting that they are putative hosts. To the best of our knowledge, no further investigations on additional host association of B. turcica were conducted. Since many but not all adult Hyalomma ticks collected from tortoises are infected, questions arise about the direction of transmission between tick and tortoises for this Borrelia species. In addition, there is no information on the potential pathogenicity of B. turcica for humans. For other Borrelia species it has been shown that resistance or sensitivity to complement-active serum can be indicative of host species association(s). In this study, we explored for the first time the in vitro survival of B. turcica isolates from Turkey (IST7) and Greece (171601G) in the presence of 50% complement-active serum of different species (tortoise, turtle, human and bird). Both isolates showed resistance to tortoise serum, partial resistance to turtle serum but did not survive human and bird serum. These data suggest that indeed tortoises are reservoir host species for B. turcica while birds or humans are not. By implication these data suggest that B. turcica is not human pathogenic. Whether or not other reptile species, such as lizards, are also potential hosts, requires further investigation. However, as the life cycle of Borrelia is closely linked to that of their hosts and vectors, in vitro studies can only give clues about the actual in vivo behavior.

Identifiants

pubmed: 31239207
pii: S1877-959X(19)30135-9
doi: 10.1016/j.ttbdis.2019.06.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1157-1161

Informations de copyright

Copyright © 2019 Elsevier GmbH. All rights reserved.

Auteurs

Sabrina Hepner (S)

German National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, Veterinärstr. 2, Oberschleissheim, 85764, Germany. Electronic address: Sabrina.Hepner@lgl.bayern.de.

Volker Fingerle (V)

German National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, Veterinärstr. 2, Oberschleissheim, 85764, Germany.

Dieter Heylen (D)

Department of Biology, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium; Interuniversity Institute for Biostatistics and statistical Bioinformatics, Hasselt University, Agoralaan Building D, 3590, Diepenbeek, Belgium.

Durdica Marosevic (D)

German National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, Veterinärstr. 2, Oberschleissheim, 85764, Germany.

Katayoon Ghaffari (K)

Clinic of Birds, Small Mammals, Reptiles and Ornamental Fish of the Ludwig-Maximilians University Munich, Faculty of Veterinary Medicine, Sonnenstr. 18, Oberschleissheim, 58764, Germany.

Mercy Okeyo (M)

German National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, Veterinärstr. 2, Oberschleissheim, 85764, Germany.

Andreas Sing (A)

German National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, Veterinärstr. 2, Oberschleissheim, 85764, Germany.

Gabriele Margos (G)

German National Reference Centre for Borrelia, Bavarian Health and Food Safety Authority, Veterinärstr. 2, Oberschleissheim, 85764, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH